Wells Fargo Adjusts Price Target on ResMed to $215 From $225
Wells Fargo has adjusted its price target for ResMed (RMD) from $225 to $215, as reported on August 7, 2026. This change is part of several analyst adjustments for ResMed on the same day, including price target changes from Jefferies, Mizuho, Morgan Stanley, KeyBanc …